Academic Jobs - Home of Higher Ed Logo

Rate My Professor Lynn Gillam

University of Melbourne

Ratings & reviews

4.08/20/2025

Always respectful and encouraging to all.

4.05/21/2025

Helps students see the value in learning.

4.02/27/2025

Always clear, engaging, and insightful.

5.02/4/2025

Great Professor!

Taught by or worked with Lynn?

Add your rating. It takes about 30 seconds.

About Lynn

Professor Lynn Gillam is Professor in Health Ethics in the Department of Paediatrics at the University of Melbourne. She serves as Academic Director and Clinical Ethicist at the Children’s Bioethics Centre, Royal Children’s Hospital Melbourne, where she leads clinical ethics consultations, ethics rounds, education sessions, and policy advice. Originally trained in philosophy with an MA from Oxford University in 1988 and in bioethics with a PhD from Monash University in 2000, she has been involved in over 200 ethics consultations at the Royal Children’s Hospital since 2005. Her research specializations encompass paediatric clinical ethics, including end-of-life decision-making, management of differences of sex development, information-giving to seriously ill children, fertility preservation for prepubertal children undergoing gonadotoxic treatment, parental refusal of treatment, and the use of high-cost investigational drugs. She developed the world’s first ethical framework for decision-making about a child’s future fertility in the context of chemotherapy and introduced the 'Zone of Parental Discretion' concept in her 2016 publication 'The zone of parental discretion: An ethical tool for dealing with disagreement between parents and doctors about medical treatment for a child,' which is widely used in clinical bioethics discussions. Other key publications include 'Fifty years of paediatric ethics' (2015), 'Ethics at the end of life: Who should make decisions about treatment limitation for young children with life-threatening or life-limiting conditions?' (2011), and 'Critical dialogue method of ethics consultation: making clinical ethics facilitation visible and accessible' (2025).